Left Ventricular Ejection Fraction and Implantable Cardioverter Defibrillator in Nonischemic Heart Failure With Reduced Ejection Fraction: Insights From DANISH.

COI Statement

Dr Butt reports advisory board honoraria from AstraZeneca and Bayer, consultant honoraria from Novartis and AstraZeneca, and travel grants from AstraZeneca outside the submitted work. Dr Thune reports speaker’s honoraria from AstraZeneca and Bristol Meyers Squibb, travel grant from AstraZeneca, and research grant from the Novo Nordisk Foundation outside the submitted work. Dr Bruun reports investigator-initiated grants from Novo Nordisk Foundation, Augustinus Foundation, Kaj Hansen Foundation, and Health Insurance Denmark outside the submitted work. Dr Gustafsson reports honoraria from Abbott, AdjuCor, AstraZeneca, Corwave, Pfizer, Bayer, and Novartis and research grants from the Novo Nordisk Foundation outside the submitted work. Dr Hassager reports institutional research grants from Novo Nordisk Foundation, Lundbeck Foundation, and the Danish Heart Foundation and speaker’s honoraria from BD and Abiomed outside the submitted work. Dr Svendsen declares institutional research grants from Medtronic outside the submitted work and reports advisory board honoraria from Medtronic and Vital Beats. Dr Pehrson reports lecture honoraria from Abbott and Bayer outside the submitted work. The other authors report no conflicts.